Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs

Journal of Controlled Release

Volumn 154, Issue 3, 2011, Pages 306-313

  Biagiotti, Sara ^a   Rossi, Luigia ^a   Bianchi, Marzia ^a   Giacomini, Elisa ^a   Pierigè, Francesca ^a   Serafini, Giordano ^a   Conaldi, Pier Giulio ^b   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

Cyclophilin A; Cyclosporine A; Drug delivery; Erythrocytes; FKBP12; Tacrolimus

Indexed keywords

CYCLOPHILIN A; CYCLOSPORINE A; ERYTHROCYTES; FKBP12; TACROLIMUS;

BIOCHEMISTRY; DIALYSIS; PHARMACOKINETICS;

DRUG DELIVERY;

CYCLOPHILIN A; CYCLOSPORIN A; FK 506 BINDING PROTEIN; IMMUNOPHILIN; RECOMBINANT PROTEIN; TACROLIMUS;

ARTICLE; BINDING AFFINITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG RELEASE; ENCAPSULATION; ERYTHROCYTE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE;

CYCLOSPORINE; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; HUMANS; IMMUNOPHILINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; PROTEIN BINDING; RECOMBINANT PROTEINS; TACROLIMUS;

EID: 80052532218     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.05.024     Document Type: Article

References (55)

1. C.J. Dunn, A.J. Wagstaff, C.M. Perry, G.L. Plosker, and K.L. Goa Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation Drugs 61 2001 1957 2016
2. J.P. Griffith, J.L. Kim, E.E. Kim, M.D. Sintchak, J.A. Thomson, M.J. Fitzgibbon, M.A. Fleming, P.R. Caron, K. Hsiao, and M.A. Navia X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex Cell 82 1995 507 522
3. D. Faulds, K.L. Goa, and P. Benfield Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders Drugs 45 1993 953 1040 (Pubitemid 23219075)
4. S. Pollard, B. Nashan, A. Johnston, P. Hoyer, P. Belitsky, P. Keown, and H. Helderman A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001 Clin. Ther. 25 2003 1654 1669 (Pubitemid 36801940)
5. D. Cattaneo, N. Perico, and G. Remuzzi From pharmacokinetics to pharmacogenomics: a new approach to tailor immunosuppressive therapy Am. J. Transplant. 4 2004 299 310 (Pubitemid 38282284)
6. M. Naesens, D.R. Kuypers, and M. Sarwal Calcineurin inhibitor nephrotoxicity Clin. J. Am. Soc. Nephrol. 4 2009 481 508
7. V.T. Armenti, M.J. Moritz, and J.M. Davison Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes Drug Saf. 19 1998 219 232 (Pubitemid 28432930)
8. S.M. Tsunoda, and F.T. Aweeka Drug concentration monitoring of immunosuppressive agents: focus on tacrolimus, mycophenolate mofetil and sirolimus BioDrugs 14 2000 355 369 (Pubitemid 32105545)
9. R.P. Kershner, and W.E. Fitzsimmons Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation Transplantation 62 1996 920 926 (Pubitemid 26360352)
10. K. Iwasaki Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics Drug Metab. Pharmacokinet 22 2007 328 335
11. N.A. Undre Pharmacokinetics of tacrolimus-based combination therapies Nephrol. Dial. Transplant. 18 Suppl 1 2003 i12 i15
12. S.B. Shin, H.Y. Cho, D.D. Kim, H.G. Choi, and Y.B. Lee Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery Eur. J. Pharm. Biopharm. 74 2 2009 164 171
13. T. Nassar, A. Rom, A. Nyska, and S. Benita Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug J. Control. Release 133 2009 77 84
14. A. Lamprecht, H. Yamamoto, H. Takeuchi, and Y. Kawashima A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles J. Control. Release 104 2005 337 346 (Pubitemid 40724934)
15. M. Chougule, B. Padhi, and A. Misra Nano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokinetics Int. J. Nanomedicine 2 2007 675 688
16. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation Eur. J. Cancer 37 2001 1590 1598 (Pubitemid 32778603)
17. V.B. Borhade, H.A. Nair, and D.D. Hegde Development and characterization of self-microemulsifying drug delivery system of tacrolimus for intravenous administration Drug Dev. Ind. Pharm. 35 2009 619 630
18. H. Yura, N. Yoshimura, T. Hamashima, K. Akamatsu, M. Nishikawa, Y. Takakura, and M. Hashida Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate J. Control. Release 57 1999 87 99 (Pubitemid 29005076)
19. A. Giordano Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus Curr. Opin. Drug Discov. Devel. 13 2010 159 168
20. A.S. Goebel, R.H. Neubert, and J. Wohlrab Dermal targeting of tacrolimus using colloidal carrier systems Int. J. Pharm. 404 1-2 2010 159 168
21. J.H. Joe, W.M. Lee, Y.J. Park, K.H. Joe, D.H. Oh, Y.G. Seo, J.S. Woo, C.S. Yong, and H.G. Choi Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus Int. J. Pharm. 395 2010 161 166
22. X. Li, W. Wang, G. Wei, G. Wang, W. Zhang, and X. Ma Immunophilin FK506 loaded in chitosan guide promotes peripheral nerve regeneration Biotechnol. Lett. 32 2010 1333 1337
23. Y.J. Park, D.S. Ryu, D.X. Li, Q.Z. Quan, D.H. Oh, J.O. Kim, Y.G. Seo, Y.I. Lee, C.S. Yong, J.S. Woo, and H.G. Choi Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate Arch. Pharm. Res. 32 2009 893 898
24. D.D. Ankola, E.W. Durbin, G.A. Buxton, J. Schafer, U. Bakowsky, and M.N. Kumar Preparation, characterization and in silico modeling of biodegradable nanoparticles containing cyclosporine A and coenzyme Q10 Nanotechnology 21 2010 065104
25. T.E. Corcoran Aerosol drug delivery in lung transplant recipients Expert Opin. Drug Deliv. 6 2009 139 148
26. A. Czogalla Oral cyclosporine A-the current picture of its liposomal and other delivery systems Cell. Mol. Biol. Lett. 14 2009 139 152
27. N. Fukata, K. Uchida, T. Kusuda, M. Koyabu, H. Miyoshi, T. Fukui, M. Matsushita, A. Nishio, Y. Tabata, and K. Okazaki The effective therapy of cyclosporine A with drug delivery system in experimental colitis J. Drug Target. 2010 [Epub ahead of print]
28. J. Kim, K.H. Chung, C.M. Lee, Y.S. Seo, H.C. Song, and K.Y. Lee Lymphatic delivery of 99mTc-labeled dextran acetate particles including cyclosporine A J. Microbiol. Biotechnol. 18 2008 1599 1605
29. J. Lai, Y. Lu, Z. Yin, F. Hu, and W. Wu Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles Int. J. Nanomedicine 5 2010 13 23
30. B. Malaekeh-Nikouei, and N. Davies Double loading of cyclosporine A in liposomes using cyclodextrin complexes PDA J. Pharm. Sci. Technol. 63 2009 139 148
31. C. Sander, and P. Holm Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation AAPS PharmSciTech 10 2009 1388 1395
32. J. Shen, Y. Deng, X. Jin, Q. Ping, Z. Su, and L. Li Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution Int. J. Pharm. 402 2010 248 253
33. S.G. Yang Biowaiver extension potential and IVIVC for BCS Class II drugs by formulation design: case study for cyclosporine self-microemulsifying formulation Arch. Pharm. Res. 33 2010 1835 1842
34. M. Magnani, L. Rossi, M. D'ascenzo, I. Panzani, L. Bigi, and A. Zanella Erythrocyte engineering for drug delivery and targeting Biotechnol. Appl. Biochem. 28 Pt 1 1998 1 6 (Pubitemid 28369899)
35. F.S. Chow, W. Piekoszewski, and W.J. Jusko Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion Drug Metab. Dispos. 25 1997 610 616 (Pubitemid 27213103)
36. L.D. Walensky, P. Gascard, M.E. Fields, S. Blackshaw, J.G. Conboy, N. Mohandas, and S.H. Snyder The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1 J. Cell Biol. 141 1998 143 153 (Pubitemid 28182647)
37. B.M. Foxwell, G. Frazer, M. Winters, P. Hiestand, R. Wenger, and B. Ryffel Identification of cyclophilin as the erythrocyte ciclosporin-binding protein Biochim. Biophys. Acta 938 1988 447 455 (Pubitemid 18067092)
38. C. Reichel, F.M. von, D. Brockmeier, and H.J. Dengler Characterization of cyclosporine A uptake in human erythrocytes Eur. J. Clin. Pharmacol. 46 1994 417 419 (Pubitemid 24199201)
39. S. Baldelli, S. Zenoni, S. Merlini, N. Perico, and D. Cattaneo Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection Clin. Chim. Acta 364 2006 354 358 (Pubitemid 43120668)
40. M. Magnani, L. Rossi, M. Bianchi, G. Serafini, E. Zocchi, M. Laguerre, and C. Ropars Improved stability of 2,3-bisphosphoglycerate during storage of hexokinase-overloaded erythrocytes Biotechnol. Appl. Biochem. 11 1989 439 444 (Pubitemid 19239235)
41. P.J. McConahey, and F.J. Dixon Radioiodination of proteins by the use of the chloramine-T method Methods Enzymol. 70 1980 210 213
42. S. Baldelli, S. Murgia, S. Merlini, S. Zenoni, N. Perico, G. Remuzzi, and D. Cattaneo High-performance liquid chromatography with ultraviolet detection for therapeutic drug monitoring of everolimus J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 816 2005 99 105 (Pubitemid 40143495)
43. J.E. Kay, C.R. Benzie, M.R. Goodier, C.J. Wick, and S.E. Doe Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506 Immunology 67 1989 473 477 (Pubitemid 19203683)
44. J.E. Kay, E. Sampare-Kwateng, F. Geraghty, and G.Y. Morgan Uptake of FK 506 by lymphocytes and erythrocytes Transplant. Proc. 23 1991 2760 2762
45. V. Annese, A. Latiano, L. Rossi, G. Lombardi, B. Dallapiccola, S. Serafini, G. Damonte, A. Andriulli, and M. Magnani Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients-a pilot uncontrolled study Am. J. Gastroenterol. 100 2005 1370 1375 (Pubitemid 40904364)
46. F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, S.E. De, A. Andriulli, and V. Annese Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled study Am. J. Gastroenterol. 103 2008 2509 2516
47. M. Castro, L. Rossi, B. Papadatou, F. Bracci, D. Knafelz, M.I. Ambrosini, A. Calce, S. Serafini, G. Isacchi, F. D'Orio, G. Mambrini, and M. Magnani Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease J. Pediatr. Gastroenterol. Nutr. 44 2007 423 426 (Pubitemid 46573223)
48. L. Rossi, S. Serafini, L. Cenerini, F. Picardi, L. Bigi, I. Panzani, and M. Magnani Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease Biotechnol. Appl. Biochem. 33 2001 85 89 (Pubitemid 32304285)
49. L. Rossi, M. Castro, F. D'Orio, G. Damonte, S. Serafini, L. Bigi, I. Panzani, G. Novelli, B. Dallapiccola, S. Panunzi, C.P. Di, S. Bella, and M. Magnani Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients Blood Cells Mol. Dis. 33 2004 57 63 (Pubitemid 38829599)
50. M.A. Wear, A. Patterson, and M.D. Walkinshaw A kinetically trapped intermediate of FK506 binding protein forms in vitro: chaperone machinery dominates protein folding in vivo Protein Expr. Purif. 51 2007 80 95 (Pubitemid 44822661)
51. L. Rossi, S. Serafini, and M. Magnani Red blood cell loading: a selection of procedures M. Magnani, Erythrocyte engineering for drug delivery and targeting 2003 Kluwer Academic/Plenum Publisher New York 1 18
52. V. Yurchenko, G. Zybarth, M. O'Connor, W.W. Dai, G. Franchin, T. Hao, H. Guo, H.C. Hung, B. Toole, P. Gallay, B. Sherry, and M. Bukrinsky Active site residues of cyclophilin A are crucial for its signaling activity via CD147 J. Biol. Chem. 277 2002 22959 22965 (Pubitemid 34967280)
53. W. Piekoszewski, F.S. Chow, and W.J. Jusko Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance Drug Metab. Dispos. 21 1993 690 698 (Pubitemid 23221766)
54. J.J. Armstrong, and S.N. Seghal Rapamycin loaded formed blood elements to induce immunosuppression 1998
55. S.F. Gothel, and M.A. Marahiel Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts Cell. Mol. Life Sci. 55 1999 423 436 (Pubitemid 29178881)